Author

R. Raghunandan

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

#protein folding Open access Nov 2026

Phase II randomized non-inferiority trial comparing the humoral immunogenicity of NDV-HXP-S and BNT162b2 vaccines in Brazil

This was a multicenter, randomized, double-blind, active-controlled and non-inferiority Phase II clinical trial, to evaluate the immunogenicity and safety of a fifth-dose booster of NDV-HXP-S, an egg-derived, inactivated COVID-19 vectored-vaccine virus using the Newcastle disease virus.

É. J. F. Peixoto de Miranda, José Alfredo de Sousa Moreira, Ricardo Sobhie Diaz et al. · Scientific Reports · 0 citations

Open access Oct 2026

Safety and immunogenicity of Thailand Government Pharmaceutical Organization (GPO) produced, COVID-19 vaccine, 10 μg HXP-GPOVac: A Phase III, double-blind, randomized trial in comparison with VAXZEVRIA.

BACKGROUND HXP-GPOVac is a Thailand-produced, egg-based, inactivated recombinant Newcastle disease virus (NDV)-chimera vaccine expressing a membrane-anchored, prefusion-stabilized SARS-CoV-2 spike (NDV-HXP-S), developed to expand vaccine access. This phase III trial evaluated the safety and immunogenicity of a single H...

Kriengkrai Prasert, S. Nakphook, Jiraphut Kittiwatanachod et al. · Vaccine · 0 citations